18329083

Source:http://linkedlifedata.com/resource/pubmed/id/18329083

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006610, umls-concept:C0013216, umls-concept:C0032207, umls-concept:C0144576, umls-concept:C0205132, umls-concept:C0220901, umls-concept:C0229671, umls-concept:C0439743, umls-concept:C0547047, umls-concept:C1522609, umls-concept:C1554112, umls-concept:C1556084, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2008-5-5
pubmed:abstractText	CA 125 assays enable treatment-response monitoring in ovarian cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/CA-125 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Platinum
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1095-6859
pubmed:author	pubmed-author:BasuyauJ PJP, pubmed-author:DalifardII, pubmed-author:EcheNN, pubmed-author:HaceneKK, pubmed-author:PichonM FMF, pubmed-author:RiedingerJ MJM
pubmed:issnType	Electronic
pubmed:volume	109
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	194-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18329083-Adult, pubmed-meshheading:18329083-Aged, pubmed-meshheading:18329083-Aged, 80 and over, pubmed-meshheading:18329083-Antineoplastic Agents, Phytogenic, pubmed-meshheading:18329083-CA-125 Antigen, pubmed-meshheading:18329083-Disease-Free Survival, pubmed-meshheading:18329083-Female, pubmed-meshheading:18329083-Follow-Up Studies, pubmed-meshheading:18329083-Humans, pubmed-meshheading:18329083-Kaplan-Meier Estimate, pubmed-meshheading:18329083-Kinetics, pubmed-meshheading:18329083-Middle Aged, pubmed-meshheading:18329083-Ovarian Neoplasms, pubmed-meshheading:18329083-Paclitaxel, pubmed-meshheading:18329083-Platinum, pubmed-meshheading:18329083-Predictive Value of Tests, pubmed-meshheading:18329083-Prognosis, pubmed-meshheading:18329083-Proportional Hazards Models, pubmed-meshheading:18329083-Retrospective Studies
pubmed:year	2008
pubmed:articleTitle	Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study.
pubmed:affiliation	Laboratoire de Biologie Médicale, Centre Georges François Leclerc, 1 rue du Pr Marion, 21034 Dijon cedex, France. jriedinger@dijon.fnclcc.fr
pubmed:publicationType	Journal Article, Multicenter Study